InvestSMART

Island Pharmaceuticals Limited (ASX: ILA) - Announcements

- Current share price for ILA : $0.400

ASX company news and announcements for Island Pharmaceuticals Limited (ILA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Island Pharmaceuticals Limited (ILA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Island Pharmaceuticals Limited (ILA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Island Pharmaceuticals Limited (ILA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$118 Quarterly Activities & Cashflow Report 30 Apr 2025 8:31AM $0.150 $0.400 risen by 166.67%
$118 Phase 2a/b clinical trial update 23 Apr 2025 9:12AM $0.155 $0.400 risen by 158.06%
$118 Notification of cessation of securities - ILA 14 Apr 2025 9:35AM $0.170 $0.400 risen by 135.29%
$118 Change in substantial holding 26 Mar 2025 4:21PM $0.190 $0.400 risen by 110.53%
$118 Ceasing to be a substantial holder 25 Mar 2025 4:35PM $0.175 $0.400 risen by 128.57%
$118 Change in substantial holding 25 Mar 2025 4:31PM $0.175 $0.400 risen by 128.57%
$118 Change in substantial holding 24 Mar 2025 4:14PM $0.180 $0.400 risen by 122.22%
$118 Spark Plus Healthcare Conference Investor Presentation 24 Mar 2025 9:35AM $0.190 $0.400 risen by 110.53%
$118 Change in substantial holding 21 Mar 2025 9:35AM $0.190 $0.400 risen by 110.53%
$118 Total of $2.72m raised from ILAO options 19 Mar 2025 9:51AM $0.170 $0.400 risen by 135.29%
$118 Notification of cessation of securities - ILA 19 Mar 2025 9:29AM $0.170 $0.400 risen by 135.29%
$118 Change of Director's Interest Notice - PL 19 Mar 2025 9:13AM $0.170 $0.400 risen by 135.29%
$118 Application for quotation of securities - ILA 19 Mar 2025 9:09AM $0.170 $0.400 risen by 135.29%
$118 Application for quotation of securities - ILA 12 Mar 2025 9:13AM $0.165 $0.400 risen by 142.42%
$118 Change of Director's Interest Notice - DF 5 Mar 2025 8:37AM $0.155 $0.400 risen by 158.06%
$118 Application for quotation of securities - ILA 5 Mar 2025 8:30AM $0.155 $0.400 risen by 158.06%
$118 Cleansing Notice 5 Mar 2025 8:26AM $0.155 $0.400 risen by 158.06%
$118 Application for quotation of securities - ILA 5 Mar 2025 8:24AM $0.155 $0.400 risen by 158.06%
$118 Application for quotation of securities - ILA 5 Mar 2025 8:23AM $0.155 $0.400 risen by 158.06%
$118 Appendix 4D & Half-Year Financial Statements 27 Feb 2025 3:13PM $0.155 $0.400 risen by 158.06%
$118 Application for quotation of securities - ILA 26 Feb 2025 9:22AM $0.145 $0.400 risen by 175.86%
$118 Change in substantial holding 19 Feb 2025 1:28PM $0.125 $0.400 risen by 220%
$118 Application for quotation of securities - ILA 19 Feb 2025 8:40AM $0.130 $0.400 risen by 207.69%
$118 Notification regarding unquoted securities - ILA 13 Feb 2025 9:14AM $0.135 $0.400 risen by 196.30%
$118 Change of Director's Interest Notice (PL) 13 Feb 2025 9:05AM $0.135 $0.400 risen by 196.30%

126 - 150 of 442 results

Page 6 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.